SCHEMBL612563

SCHEMBL612563

CCCCNC.CO[SiH](OC)OC

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.55
TSHR P16473 2/20 0.38
CA12 O43570 2/20 0.33
CA14 Q9ULX7 2/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
ADH1B P00325 1/20 0.33
ADH1C P00326 1/20 0.33
ADH1A P07327 1/20 0.33
ADH7 P40394 1/20 0.33
CA7 P43166 1/20 0.33
ALDH1A1 P00352 1/20 0.33
ACHE P22303 6/20 0.32
HTR1B P28222 1/20 0.31
S1PR2 O95136 3/20 0.30
S1PR4 O95977 3/20 0.30
S1PR1 P21453 3/20 0.30
S1PR3 Q99500 3/20 0.30
S1PR5 Q9H228 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11141359 0.90 EPHX1 (0.71) EPHX1TSHRCA12CA14CA2
SCHEMBL12081562 0.85 EPHX1 (0.50) EPHX1TSHRCA12CA14CA1
SCHEMBL2390795 0.83 EPHX1 (0.39) EPHX1
SCHEMBL2600 0.83
SCHEMBL10430076 0.81 TSHR (0.55) EPHX1TSHRCA12CA14CA1
SCHEMBL612969 0.80 EPHX1 (0.50) EPHX1TSHRCA12CA14CA1
SCHEMBL8380351 0.80 EPHX1 (0.39) EPHX1TSHRCA12CA14CA1
Water SCHEMBL22231652 0.80
Bromide SCHEMBL22574897 0.80
Iodide SCHEMBL9110774 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2838904-B1 PROCESS FOR PREPARING (METH)ACRYLAMIDO-FUNCTIONAL SILANES BY THE REACTION OF AMINOALKYL ALKOXYSILANES WITH ACRYLIC ACID ANHYDRIDE EVONIK OPERATIONS GMBH (DE) 2020-04-08 EP claimed
EP-2838905-B1 NOVEL, MONO-SYNTHESIZABLE, SPONTANEOUSLY WATER-SOLUBLE, SUBSTANTIALLY VOC-FREE, ENVIRONMENTALLY FRIENDLY (METH)ACRYLAMIDO-FUNCTIONAL SILOXANOL SYSTEMS, PROCESS FOR THEIR PREPARATION AND USE EVONIK DEGUSSA GMBH (DE) 2019-09-25 EP claimed
EP-2838936-B1 NOVEL, EASILY PRODUCIBLE, VOC-REDUCED, ENVIRONMENTALLY FRIENDLY (METH)ACRYLAMIDO-FUNCTIONAL SILOXANE SYSTEMS, PROCESSES FOR THE PREPARATION AND USE THEREOF EVONIK DEGUSSA GMBH (DE) 2016-11-23 EP claimed
US-9441094-B2 Easily preparable, reduced-VOC, environmentally friendly (meth)acrylamido-functional siloxane systems, process for preparation thereof and use EVONIK DEGUSSA GMBH (DE) 2016-09-13 US claimed
US-9353136-B2 Process for preparing (meth)acrylamido-functional silanes by the reaction of aminoalkyl alkoxysilanes with acrylic acid anhydride EVONIK DEGUSSA GMBH (DE) 2016-05-31 US claimed
EP-2421874-B1 COMPOSITION CONTAINING QUATERNARY AMINO-FUNCTIONAL ORGANOSILICON COMPOUNDS AND PRODUCTION AND USE THEREOF EVONIK DEGUSSA GMBH (DE) 2015-09-30 EP claimed
US-20150152247-A1 NOVEL, EASILY PREPARABLE, REDUCED-VOC, ENVIRONMENTALLY FRIENDLY (METH)ACRYLAMIDO-FUNCTIONAL SILOXANE SYSTEMS, PROCESS FOR PREPARATION THEREOF AND USE EVONIK INDUSTRIES AG (DE) 2015-06-04 US claimed
US-20150090930-A1 PROCESS FOR PREPARING (METH)ACRYLAMIDO-FUNCTIONAL SILANES BY THE REACTION OF AMINOALKYL ALKOXYSILANES WITH ACRYLIC ACID ANHYDRIDE EVONIK INDUSTRIES AG (DE) 2015-04-02 US claimed
US-20150080594-A1 NOVEL, EASILY SYNTHESIZABLE, SPONTANEOUSLY WATER-SOLUBLE, ESSENTIALLY VOC-FREE, ENVIRONMENTALLY FRIENDLY (METH)ACRYLAMIDO-FUNCTIONAL SILOXANOL SYSTEMS, PROCESS FOR PREPARATION THEREOF AND USE EVONIK INDUSTRIES AG (DE) 2015-03-19 US claimed
US-8979996-B2 Composition containing quaternary amino-functional organosilicon compunds and production and use thereof EVONIK DEGUSSA GMBH (DE) 2015-03-17 US claimed
US-20140208981-A1 COMPOSITION CONTAINING QUATERNARY AMINO-FUNCTIONAL ORGANOSILICON COMPOUNDS AND PRODUCTION AND USE THEREOF EVONIK DEGUSSA GMBH (DE) 2014-07-31 US claimed
US-8728225-B2 Composition containing quaternary amino-functional organosilicon compounds and production and use thereof EVONIK DEGUSSA GMBH (DE) 2014-05-20 US claimed
US-20120037040-A1 COMPOSITION CONTAINING QUATERNARY AMINO-FUNCTIONAL ORGANOSILICON COMPOUNDS AND PRODUCTION AND USE THEREOF EVONIK DEGUSSA GMBH (DE) 2012-02-16 US claimed
US-12595337-B2 Cross-linkable compositions based on organyl oxysilane-terminated polymers WACKER CHEMIE AG (DE) 2026-04-07 US disclosed
US-12304988-B2 Acrylic polymers having controlled placement of functional groups AVERY DENNISON CORPORATION (US) 2025-05-20 US disclosed
CN-114423837-B Long term removable film 艾利丹尼森公司 2024-05-24 CN disclosed
US-7084203-B2 Self-reactive/curable water-based solid adhesive and method of bonding with the self-reactive/curable water-based solid adhesive KONISHI CO., LTD. (JP) 2006-08-01 US disclosed
EP-1607423-A1 AQUEOUS SILYLATED URETHANE COMPOSITION, AQUEOUS ADHESIVES FOR WRAPPING, AND AQUEOUS CONTACT ADHESIVES Konishi Co., Ltd. (JP) 2005-12-21 EP disclosed
US-20040132864-A1 Self-reactive/curable water-based solid adhesive and method of bonding with the self-reactive/curable water-based solid adhesive KONISHI CO., LTD. (JP) 2004-07-08 US disclosed
EP-1431366-A1 SELF−REACTIVE/CURABLE WATER−BASED SOLID ADHESIVE AND METHOD OF BONDING WITH THE SELF−REACTIVE/CURABLE WATER−BASED SOLID ADHESIVE KONISHI CO., LTD. (JP) 2004-06-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12595337-B2 Cross-linkable compositions based on organyl oxysilane-terminated polymers SMC3, SMC2, SMC1A EPHX1 3655/4885TSHR 3591/4885CA12 445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.